Clinical Trial Update: Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the onset of action of Advair HFA 115/21 with Symbicort pMDI 160/4.5 in asthma patients, measured by impulse oscillometry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Advair HFA 115/21 (fluticasone propionate/salmeterol)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: Allergy and Asthma Center of El Paso | Conditions: Asthma | Phase 4 | Status: UNKNOWN